Elizabeth Liz Canis
Senior Advisor @ Foresite Capital
Elizabeth Liz Canis is a Series B investor at Foresite Capital focused on Medical and Health Care. Elizabeth Liz Canis
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Elizabeth Liz Canis invests in
Stages Elizabeth Liz Canis invests in
Countries Elizabeth Liz Canis invests in
Investment Focus
Industry
- Medical 1 (33%)
- Health Care 1 (33%)
Stage
- Series B 1 (33%)
- Series C 1 (33%)
- Series D 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Thyme Care
|
Thyme Care is a healthcare company that provides oncology care management services. The company offers a patient- and provider-integrated oncology solution, partnering with health plans to facilitate whole-person care for their members. Thyme Care seeks to revolutionize cancer care by providing personalized and holistic support to patients. Thecompany envisions a future where every cancer patient can access high-quality, individualized care that meets their unique needs and circumstances. | $97M / Series D / Sep 25, 2025 | |
|
Thyme Care
|
Thyme Care is a healthcare company that provides oncology care management services. The company offers a patient- and provider-integrated oncology solution, partnering with health plans to facilitate whole-person care for their members. Thyme Care seeks to revolutionize cancer care by providing personalized and holistic support to patients. Thecompany envisions a future where every cancer patient can access high-quality, individualized care that meets their unique needs and circumstances. | $55M / Series C / Jul 16, 2024 | |
|
Thyme Care
|
Thyme Care is a healthcare company that provides oncology care management services. The company offers a patient- and provider-integrated oncology solution, partnering with health plans to facilitate whole-person care for their members. Thyme Care seeks to revolutionize cancer care by providing personalized and holistic support to patients. Thecompany envisions a future where every cancer patient can access high-quality, individualized care that meets their unique needs and circumstances. | $60M / Series B / Aug 21, 2023 |
Co-Investors
About Foresite Capital
Foresite Capital is a healthcare and life sciences investment firm. They take a data-driven approach to invest in startups that employ biology and big data to improve healthcare, such as 10x Genomics, Relay Therapeutics, Element Biosciences, and Inscripta.
Foresite Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dorothy Margolskee
Managing Director
|
|||
James Tananbaum
Founder and CEO
|
|||
Stephen C. Peterson
Partner
|
|||
Dennis D. Ryan
CFO & Managing Director
|
|||
|
Elizabeth Liz Canis
Senior Advisor
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Elizabeth Liz Canis invest in?
Elizabeth Liz Canis invests primarily in Medical and Health Care startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Elizabeth Liz Canis last invest?
The most recent investment recorded for Elizabeth Liz Canis closed in Sep 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
